Success for Kadimastem: 97% of Warrants (Series 4) Exercised for NIS 3.6M
- sherzl
- Nov 14, 2018
- 1 min read
Ness Ziona, Israel, November 11, 2018, Israeli biotechnology company Kadimastem (TASE: KDST) announces that, at the end of the exercise period of the company's Series 4 warrants, 4.82 warrants were exercised, constituting 97% of the total amount of the warrants.
The total gross proceeds received by the Company from the exercise of the warrants is NIS 3.6 million.
Mr. Yossi Ben-Yosef, CEO of the company, said: "I see the 97% exercise rate of the warrants as a success, and thank the warrant-holder public for its vote of confidence in the company and in its potential."
In Eggy Car, your mission is to traverse the entire distance without fracturing the egg. Precise acceleration and deceleration are required to maintain the egg's viability. Each meter traversed contributes to your score.